Market Cap 2.61B
Revenue (ttm) 178.96M
Net Income (ttm) -159.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.12%
Debt to Equity Ratio 0.00
Volume 1,213,700
Avg Vol 1,888,206
Day's Range N/A - N/A
Shares Out 152.27M
Stochastic %K 75%
Beta 2.06
Analysts Strong Sell
Price Target $17.14

Company Profile

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a pat...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 659 0067
Fax: 206 659 0667
Address:
1165 Eastlake Avenue East, Seattle, United States
Treasury225
Treasury225 Oct. 23 at 10:49 PM
$ADPT what the heck is happening after hours?
2 · Reply
Whales22
Whales22 Oct. 23 at 7:25 AM
How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $ADPT $BTAI $DUO $CODX Watchlist..
0 · Reply
Treasury225
Treasury225 Oct. 22 at 2:11 PM
$ADPT would love to know the story behind the 565,000 shares that traded at 16:27 yesterday that seemed to have a carry over to this mess of an opening today. Makes me question the motives behind this mornings price target update…..
1 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 12:10 PM
BTIG has updated their rating for Adaptive Biotechnologies ( $ADPT ) to Buy with a price target of 19.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Oct. 21 at 8:02 PM
Result summaries are very crucial to keep track of how the strategy is going. Here's track record showing the results for Small + Mid cap stocks. Will next trade $RXRX + $ADPT and more like I did for small + mid cap stocks when H% is low. Do you see why I only buy when H% is low? All include timestamps + buy fills for everything. The result speaks for itself.
0 · Reply
WAJeff
WAJeff Oct. 15 at 8:09 PM
$ADPT $17.14 52 week high
0 · Reply
WAJeff
WAJeff Oct. 15 at 5:44 PM
More $ADPT sold at $16.50, $16.79 52 week high. This is up 175.4% ytd
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 1:57 PM
Piper Sandler updates rating for Adaptive Biotechnologies ( $ADPT ) to Overweight, target set at 15 → 20.
0 · Reply
DARKP00L
DARKP00L Oct. 13 at 1:20 PM
$ADPT 09:19 on Oct. 13 2025 JP Morgan Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $17 #tradeideas
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:03 PM
Keep a close watch on CMCT! $TROX $OCGN $SKYE $ADPT -
1 · Reply
Latest News on ADPT
Top 3 Health Care Stocks That May Collapse This Quarter

Dec 11, 2024, 6:55 AM EST - 11 months ago

Top 3 Health Care Stocks That May Collapse This Quarter

FNA NAMS


Adaptive Biotechnologies: Making Some Progress

Nov 26, 2024, 10:53 AM EST - 11 months ago

Adaptive Biotechnologies: Making Some Progress


Treasury225
Treasury225 Oct. 23 at 10:49 PM
$ADPT what the heck is happening after hours?
2 · Reply
Whales22
Whales22 Oct. 23 at 7:25 AM
How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $ADPT $BTAI $DUO $CODX Watchlist..
0 · Reply
Treasury225
Treasury225 Oct. 22 at 2:11 PM
$ADPT would love to know the story behind the 565,000 shares that traded at 16:27 yesterday that seemed to have a carry over to this mess of an opening today. Makes me question the motives behind this mornings price target update…..
1 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 12:10 PM
BTIG has updated their rating for Adaptive Biotechnologies ( $ADPT ) to Buy with a price target of 19.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Oct. 21 at 8:02 PM
Result summaries are very crucial to keep track of how the strategy is going. Here's track record showing the results for Small + Mid cap stocks. Will next trade $RXRX + $ADPT and more like I did for small + mid cap stocks when H% is low. Do you see why I only buy when H% is low? All include timestamps + buy fills for everything. The result speaks for itself.
0 · Reply
WAJeff
WAJeff Oct. 15 at 8:09 PM
$ADPT $17.14 52 week high
0 · Reply
WAJeff
WAJeff Oct. 15 at 5:44 PM
More $ADPT sold at $16.50, $16.79 52 week high. This is up 175.4% ytd
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 1:57 PM
Piper Sandler updates rating for Adaptive Biotechnologies ( $ADPT ) to Overweight, target set at 15 → 20.
0 · Reply
DARKP00L
DARKP00L Oct. 13 at 1:20 PM
$ADPT 09:19 on Oct. 13 2025 JP Morgan Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $17 #tradeideas
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:03 PM
Keep a close watch on CMCT! $TROX $OCGN $SKYE $ADPT -
1 · Reply
WallStreetBuyDip
WallStreetBuyDip Oct. 9 at 7:43 PM
Result summaries are very crucial to keep track of how the strategy is going. Here's track record showing the results for Small + Mid cap stocks. Will next trade $RXRX + $ADPT and more like I did for small + mid cap stocks when H% is low. Do you see why I only buy when H% is low? All include timestamps + buy fills for everything. The result speaks for itself.
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 9:38 AM
$ADPT: Unusual Options Activity Alerted CALL flow observed 70x contracts at Strike price of $12.5 Exp on 01/16/2026 with Premium of $27K and showing BULLISH Sentiment
1 · Reply
Treasury225
Treasury225 Oct. 2 at 2:48 PM
$ADPT looks like Guggenheim can’t support their touts.
1 · Reply
Treasury225
Treasury225 Sep. 30 at 8:12 PM
$ADPT WOW! Guggenheim carries some weight here!!!! So many positive technical things happening too many to mention. GREAT DAY
0 · Reply
Stella_Stone_59
Stella_Stone_59 Sep. 30 at 7:18 PM
$ADPT Naysayers faded .28. The chart’s answer: hold my beer—make it .30. 🍺🚀 $BNKK
0 · Reply
DARKP00L
DARKP00L Sep. 30 at 3:27 PM
$ADPT 11:07 on Sep. 30 2025 Adaptive Biotechnologies shares are trading higher after Guggenheim initiated coverage with a Buy rating and a $20 price target. #tradeideas
0 · Reply
ChrisJohnson90
ChrisJohnson90 Sep. 30 at 2:53 PM
$ADPT Broooo $BNKK getting institutional LOVE 💎🙌 I’m BTFD till GAPUP $1+ 🚀🚀🌕 LFG fam!
0 · Reply
jgalfano4
jgalfano4 Sep. 30 at 2:42 PM
$ADPT Nice chart on all 3 - Daily, Weekly, Monthly. Rounded bottom with heavy buying volume. Looks to be heading north. Monthly chart below.
0 · Reply
ChrisJohnson90
ChrisJohnson90 Sep. 30 at 2:40 PM
$ADPT Tiny float + DeFi pivot + funds onboard = STRG setup. Phase 1: quiet accumulation → Phase 2: PUMP. Next stop $0.60–0.80?
0 · Reply
DARKP00L
DARKP00L Sep. 30 at 2:40 PM
$ADPT 10:16 on Sep. 30 2025 Guggenheim Initiates Coverage On Adaptive Biotechnologies with Buy Rating, Announces Price Target of $20 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Sep. 30 at 2:16 PM
Guggenheim updates rating for Adaptive Biotechnologies ( $ADPT ) to Buy, target set at 20.
0 · Reply
notreload_ai
notreload_ai Sep. 30 at 11:53 AM
Guggenheim rated $ADPT a "Buy." It dominates blood cancer testing and will see major growth. "Shares are currently undervalued." https://notreload.xyz/adaptive-biotechnologies-dominant-cancer-test-provider/
0 · Reply